Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2-adrenergic receptors involves multiple subsites.
Open Access
- 1 May 1990
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 9 (5) , 1471-1476
- https://doi.org/10.1002/j.1460-2075.1990.tb08264.x
Abstract
The molecular basis of ligand binding selectivity to beta‐adrenergic receptor subtypes was investigated by designing chimeric beta 1/beta 2‐adrenergic receptors. These molecules consisted of a set of reciprocal constructions, obtained by the exchange between the wild‐type receptor genes of one to three unmodified transmembrane regions, together with their extracellular flanking regions. Eight different chimeras were expressed in Escherichia coli and studied with selective beta‐adrenergic ligands. The evaluation of the relative effect of each chimeric exchange on ligand binding affinity was based on the analysis of delta G values, calculated from the equilibrium binding constants, as a function of the number of substituted beta 2‐adrenergic receptor transmembrane domains. The data showed that the contribution of each exchanged region to subtype selectivity varies with each ligand; moreover, while several regions are critical for the pharmacological selectivity of all ligands, others are involved in the selectivity of only some compounds. The selectivity displayed by beta‐adrenergic compounds towards beta 1 or beta 2 receptor subtypes thus results from a particular combination of interactions between each ligand and each of the subsites, variably distributed over the seven transmembrane regions of the receptor; these subsites are presumably defined by the individual structural properties of the ligands.This publication has 29 references indexed in Scilit:
- Cloning of the cDNA for the human beta 1-adrenergic receptor.Proceedings of the National Academy of Sciences, 1987
- Structural features required for ligand binding to the beta-adrenergic receptor.The EMBO Journal, 1987
- The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of the sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis.Journal of Biological Chemistry, 1987
- Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization.Proceedings of the National Academy of Sciences, 1987
- Identification of residues required for ligand binding to the beta-adrenergic receptor.Proceedings of the National Academy of Sciences, 1987
- cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.Proceedings of the National Academy of Sciences, 1987
- Mutagenesis by random linker insertion into the lamB gene of Escherichia coli K12Molecular Genetics and Genomics, 1986
- Probing the topology of a bacterial membrane protein by genetic insertion of a foreign epitope; expression at the cell surface.The EMBO Journal, 1986
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985
- SIMULTANEOUS DETERMINATION OF BETA-1 AND BETA-2-ADRENERGIC RECEPTORS IN TISSUES CONTAINING BOTH RECEPTOR SUBTYPES1979